FindTrial
Sign In

Comparison of effect of Dexmedetomidine when given as Intravenous route and intraperitoneal route in Laparoscopic cholecystectomy

Efficiency of intravenous Dexmedetomidine versus intraperitoneal Dexmedetomidine in Laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033582
Enrollment
44
Registered
2021-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R17- Unspecified jaundice

Interventions

Intervention1: Dexmedetomidine given intraperitoneal route: Inj.bupivacaine plain 0.25 % (40 ml)+Dexmedetomidine (0.5 mcg/ kg) given to patients after removal of gall bladder via intraperitoneal route

Sponsors

Veer Surendra Sai institute Of Medical Sciences And Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients posted laparoscopic cholecystectomy under general anaesthesia 2.Age 18-60 years 3.ASA grade I and II

Exclusion criteria

Exclusion criteria: 1.Patients with history of allergy to any medication 2.BMI >30Kg/m2 3.Preoperative HR 4.Patients using antihypertensive drug like clonidine(a2 adrenergic agonist 5.Renal or hepatic insufficiency 6.Patients with bleeding disorders 7.Patients with psychiatric disorders 8.Surgical procedure converted to open cholecystectomy

Design outcomes

Primary

MeasureTime frame
As compared to IV Dexmedetomedine IP Dexmeditimedine might have not inferior for a better post-operative analgesic effect in Laparoscopic Cholecystectomy under general anaesthesia. Timepoint: Upto 24 hours—

Secondary

MeasureTime frame
1.To observe the incidence of adverse effects 2.To calculate the total dose of analgesiaTimepoint: Upto 24 hours—

Countries

India

Contacts

Public ContactPradipta Kumar Patel

Department of Anesthesiology, VSSIMSAR, Burla

patelpradipta@gmail.com9437062284

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026